COVID-19, syringe needle

The first World Trade Organization meeting to discuss a draft agreement to temporarily waive intellectual property rights for COVID-19 vaccines went “very well”, its chair said on May 6.

A deal on an intellectual property waiver for Covid-19 vaccines at the World Trade Organization (WTO) was no closer to acceptance on May 31 despite Washington’s backing, due to expected scepticism about a new draft, sources close to the talks told Reuters.